Job title: Director, Toxicology
Dr. Gerry Rowse currently serves as a Direrctor of Toxicology and Pharmacokinetics at Zymeworks, where he is responsible for the development of product candidates from the IND-enabling studies through clinical trials. Dr. Rowse was part of the Zymeworks team that enabled the advancement of ZW25 and ZW49 into the clinic. Prior to his current role, Dr. Rowse work in various roles at Lundbeck as well as other small start-up biotechs. He received his PhD in Biology from the University of British Columbia and completed a post-doctoral fellowship in breast cancer research at the Mayo Clinic.